Pharmaconsp. z o.o.

Activities of holding companies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2009-10-27
Share capital
50,000.00 PLN
Registered address
ul. Francuska 35, 40-027 Katowice, Poland
Electronic delivery address
AE:PL-78224-21992-JDUSU-29

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk. Na dzień 31.12.2025 r. skumulowane straty wyniosły 302 352,28 zł i przewyższyły sumę kapitału zapasowego i kapitałów rezerwowych oraz jedną drugą kapitału zakładowego o kwotę 105 545,05 zł. Stosownie do wymogów art. 233 ustawy z dnia 7.12.2023 r. KSH (Dz.U. z 2024 r. poz. 18 z późniejszymi zmianami) Nadzwyczajne Zgromadzenie Wspólników w dniu XX marca 2026 r. podjęło uchwałę o kontynuowaniu działalności firmy.

From the notes

Current income tax (CIT due)$0
Profit allocationNo decision
Contingent liabilities$28,181,538

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 68 days for 2021).

  • 202506/07/2026
  • 202407/07/2025
  • 202314/07/2024
  • 202217/08/2023
  • 202121/09/2022
  • 202008/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Trademarks

Pharmacon currently holds no active trademarks with the Polish Patent Office. 10 marks have expired or were not registered. The first mark was filed in 2008.

MarkNumberClassesStatusProtected until
PHARMALAB(word)Z.3786045, 35, 44Proceedings discontinued –
DERMOLAB(word)Z.3591375, 10, 35, 44Proceedings discontinued –
DERMOFARMACJA(word)Z.3479205, 35, 44Proceedings discontinued –
MAXPHARM(word)Z.34791635, 44Not registered –
OPENGSM(word)Z.34597835Proceedings discontinued –
MarkProtected until
PHARMALAB(word)–
DERMOLAB(word)–
DERMOFARMACJA(word)–
MAXPHARM(word)–
OPENGSM(word)–

Authorized Representatives

Krzysztof Gawronage 50 – President of the Management Board

Manner of representation

Where the management board is a multi-member management board, joint action by two members of the management board or one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company. In the case of a one-person management board, the company is represented by the President of the Management Board independently.

Ownership

OwnerSharesShare valueStake
Farmea sp. z o.o.
500$13,506.21100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2010-02-01.

Debt

No entries in the National Debtors Register (KRZ).

Secured liabilities

Type
Registered pledge

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Competitors

Name
MurapolS.A.
Press Glass HoldingS.A.
Mostostal ZabrzeS.A.
RolmexS.A.
Dalpo Polandsp. z o.o.
BargS.A.
WistilS.A.
AxiaS.A.
Arcade Bee GroupS.A.
BP 24sp. z o.o.

Change history

DateEvent
2023-10-25Address change
2023-10-25PKD change
2018-09-07Address change
2018-09-07PKD change
2015-01-23Address change

FAQ

Last updated: 2026-10-13